ceforanide

23  relevant articles (7 outcomes, 5 trials/studies) found for this Drug

7-(alpha-(2-aminomethylphenyl)acetamido)-3-((1-carboxymethyltetrazol-5-ylthio)methyl)-3-cephem-4-carboxylic acid; BL-S 786; BL-S786R; cefaronide; ceforanide, monosodium salt; (6R-trans)-7-(((2-(aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid

Relationship Network

Drug Context: Research Results

Related Diseases

1.	Infection 03/01/1984 - "Fifty-two patients with 56 infections due to susceptible organisms received ceforanide, 0.5 g, 1 g, or 2 g, intramuscularly or intravenously every 12 hours for four to 60 days (average: 14.1 days)" 09/01/1983 - "Efficacy and safety of ceforanide in the treatment of childhood infections." 09/01/1979 - "Twenty-seven patients with infections due to susceptible organisms received ceforanide, 0.5, 1, or 2 g, intramuscularly or intravenously every 12 h for 6 to 28 days" 03/01/1982 - "Considering the minimal inhibitory concentrations of these drugs for staphylococci, cefamandole and ceforanide should provide adequate protection against infection by these organisms for the duration of the surgical procedure." 12/01/1984 - "More infections were seen among cephalothin recipients (8 deep, 32 total) than among ceforanide recipients (1 deep, 17 total)" Order ALL the reference details at left...
2.	Endocarditis 01/01/1984 - "Ceforanide appears to be a safe, efficacious, convenient, and relatively inexpensive drug for treating staphylococcal endocarditis in parenteral drug abusers." 01/01/1984 - "Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers." 02/01/1981 - "Ceforanide proved to be a useful agent in the treatment of right-sided endocarditis due to susceptible S" 02/01/1981 - "Ceforanide administered parenterally twice daily was used as the sole agent to treat 17 patients with right-sided endocarditis due to Staphylococcus aureus or nonenterococcal streptococci" 02/01/1981 - "Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis." Order ALL the reference details at left...
3.	Bacterial Pneumonia 01/01/1979 - "These studies suggest that ceforanide is a safe and effective agent for the treatment of adult patients with bacterial pneumonia due to S" 01/01/1979 - "Ceforanide (BL-S786) in the treatment of community-acquired bacterial pneumonia." 11/01/1981 - "In a randomized prospective study, patients with community-acquired bacterial pneumonia were treated with ceforanide at 0.5 g every 12 h (28 cases) or with cefazolin at 1.0 g every 8 h (26 cases)" Order ALL the reference details at left...
4.	Urinary Tract Infections (Urinary Tract Infection) 11/01/1982 - "Clinical trials indicate that ceforanide is effective in the treatment of skin and soft tissue, pulmonary and urinary tract infections, bone and joint infections, and endocarditis" Order ALL the reference details at left...
5.	Pneumonia (Pneumonitis) 11/01/1981 - "Ceforanide appears to be as safe and effective as cefazolin for the therapy of pneumonia caused by S" 11/01/1981 - "Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cephalothin (Cefalotin)
2.	Cefazolin (Ancef)
3.	Cefamandole
4.	Nafcillin
5.	Methicillin (Metin)
6.	Cephapirin (Cefapirin)
7.	Cefonicid (Monocid)
8.	Cefuroxime (Zinacef)
9.	Gentamicins (Gentamicin)
10.	Creatinine

Related Therapies and Procedures

1.	Antibiotic Prophylaxis
2.	Vaginal Hysterectomy
3.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)
4.	Renal Dialysis (Hemodialysis)